Our products
GIP / GLP-1 receptor agonist
Tirzepatide
A peptide that activates both GIP and GLP-1 receptors, two pathways involved in metabolic regulation.
How it works
Its dual-receptor activity influences glucose-dependent insulin secretion and appetite signalling. Researchers study how the two pathways interact in glucose and energy regulation.
Research context
Tirzepatide is the active ingredient in approved prescription medicines for specific indications. Approval of those medicines does not establish the suitability of research material for human use.